for osteoporosis and osteopenia cases; however, recent studies testing zoledronic acid (5 mg) in annual doses over a period of 3 years for postmenopausal osteoporosis patients have also shown positive results in reducing the risk of long bone fractures. 5 In rat animal model, a single dose of zoledronic acid has proven to be effective in preventing bone diseases when injected with tumour cells. 6 Metcalf et al 7 observed
the effect of bisphosphonates on angiogenesis, showing the dose-dependent characteristic of these drugs on endothelial cells: the higher the dose, the lower the capacity of formation of new vessels. In vitro studies have shown that nitrogen-containing bisphosphonates have effect on almost all cells, including cultures of osteoclasts, osteoblasts, macrophages and epithelial and endothelial cells, with the osteoclasts and macrophages being more sensitive to low concentrations (1-10 μmol/L) in vitro. 8 Studies in animals have also clarified the relationship between bisphosphonates use and changes in alveolar bone tissue. 9 Factors such as stagnation of osteoclastic activity and angiogenesis, which are fundamental to bone repair, have been observed. 10, 11 This study aimed to analyse the inflammatory response of alveolar bone after pulp injury in rats submitted to two different regimens of zoledronic acid therapy. 
| METHODS

| Ethical approval
| Experimental design
Study sample was composed of 28 male Wistar albino rats, aged 60 days weighting on average 250 g. Sample size calculation was based in 5% significance level for 80% statistical power, 5.0% minimal detectable difference between means, and 1.2% expected SD of the residuals, having bone necrosis area as primary outcome. Six animals were set to each group, in accordance with studies from. [10] [11] [12] Predicting losses during the study, the final sample was set at seven animals per group. The sample was divided into four groups, each with seven rats, using block randomization. Animals were kept in the Animal Experimental Unit housing for the entire study period, at a room temperature of 23°C (±1°C), having ad libitum access to commercial solid feed and water. GTa test group received a weekly intraperitoneal zoledronic acid (Zoledronic Acid ® ; Eurofarma S.A, RJ, Brazil) dose of 0.2 mg/kg for 3 weeks, and
GTb test group received the same dose for 8 weeks. Physiological saline doses, equivalent to those of the medication, were administered to the control groups GCa and GCb. At 3 weeks, test and control animals were submitted to a surgical procedure simulating pulp and periapical injury under the effect of 2% xylazine hydrochloride (Anasedan; Sespo Indústria e Comércio Ltda, Jacareí, SP, Brazil) and 10% ketamine hydrochloride (Ketamina Agener-Ketamine 10%; União Química Farmacêutica Nacional S/A, São Paulo, SP, Brazil) at doses of 10 and 100 mg/kg, respectively. 13 To create such defect in the dental crown of the lower left first molar, a spherical bur was used. The defect involved the entire volume of the bur (1.4 mm deep and wide), extending thereby to the dental furcation. The animals were euthanized in a CO 2 chamber 8 weeks after the start of the study. A necropsy was performed immediately afterwards.
| Image assessment
Tomographic images (Kodak 9000 Carestream SystemCarestream Health, Inc; New York, NY, USA) of the samples were obtained using the technical parameters: 60 kVp, 4 mA, 75 μm voxel. Images were acquired and stored using DICOM protocol, reconstructed and analysed using the free software Image J ® (version 1.46) (Image J ® , version 1.46
National Institutes of Health Bethesda, MD, USA), and converted to 8-bit (256 grey levels). The relationship between the attenuation limits of the X-ray beams and the grey level (GL) values of the rat alveolar bone tissue was examined for analysis of image density. The area to be evaluated, region of interest (ROI), was determined as the region corresponding to the alveolar bone tissue surrounding the roots of the lower left first molar.
| Histological assessment
To allow histological analysis, tissue samples were decalcified in 5% nitric acid solution (100% nitric acid; F.Maia Industria e Comércio Ltda, Cotia, SP, Brazil) for approximately 2 weeks. Specimens were then dehydrated in increasing concentrations of alcohol, embedded in paraffin and processed for routine histology. Slides were stained with haematoxylin and eosin (HE) and mounted in Canada balsam.
Interpretation of the histological slides was conducted by a single blinded oral pathologist using a binocular clinical microscope (Olympus CX21FS1 (Olympus CX21FS1, Center Valley, PA, USA)) at 40×, 100× and 400× magnification. The dental apices areas extending to the middle third of the distal root of the lower first molar were evaluated in the tooth where the crown defect had been performed. Histological slides that showed displaced roots or those not included in the region of interest were excluded. Qualitative analysis was performed attributing scores for intensity of inflammatory infiltrate, type of infiltrate, vascularization, presence of bone necrosis, and dental resorption. 14, 15 Scores for the intensity of inflammatory infiltrate and presence of vascularization were assigned ( Figure 1 ) as follows: − (0%), + (1%-30%), ++ (30%-60%), +++ (>60%). Inflammatory infiltrate was defined as acute or chronic according to the cellular characteristics. Necrosis and resorption were evaluated as present (yes) or absent (no).
| Statistical analysis
Shapiro-Wilk test was used on results from density analysis of grey levels to verify normality of the data, followed by t test with a 5% significance level (P < 0.05). Chi-square test was applied to data scores to verify association between groups, assuming a 5% significance level (P < 0.05).
| RESULTS
One early death occurred in GCa group after anaesthesia induction. The remaining rats showed no clinical or surgical complication during the study. GCa and GTa groups were compared regarding the influence of the zoledronic acid on the alveolar bone inflammatory response after discontinued therapy at third week. Statistical differences (P < 0.05) were observed in the tomographic analysis for the variables: mean grey levels (P = 0.02), minimum value grey levels (P = 0.03) and maximum value grey levels (P = 0.01; Table 1 , Figure 2) . Histological analysis revealed a more intense vascular reaction in GCa in comparison with the GTa group. The alveolar bone in the GTa group proved to be more compact, exhibiting less vascular structures and nutrition zones in the regions where there was no inflammatory reaction (Table 2, Figure 3 ).
GCb and GTb groups were compared regarding the influence of zoledronic acid on the alveolar bone inflammatory response after an 8-week therapy period. No statistical differences between groups comparing the tomographic images were observed. However, histological analysis showed intense zones of fibrosis and areas of necrosis associated with the acute inflammatory process in some of the GTb 
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Mean group specimens near the furcation region, often found to be fractured. The presence of fibrous tissue and chronic inflammation associated with remodelling of the furcation region could be observed in the GCb group images. In contrast, bone resorption and remodelling in the interradicular zone in GTb group were delayed ( Figure 3 ).
| DISCUSSION
Bisphosphonates have been focus of many recent studies in the scientific community, especially regarding the occurrence of osteonecrosis of the jaw (BONJ) as a side effect. However, it remains unclear whether zoledronic acid use, isolated, is able to modify the inflammatory response in alveolar bone tissue following pulp and periapical injury. This study used 60-day-old rats, which present at this stage sexual and musculoskeletal maturity equivalent to that of an adult rat. According to Marx et al 2 in his report on 119 human cases, the mean induction time for the appearance of osteonecrosis lesions of the jaw from bisphosphonates use was 9.4 months, for those treated with zoledronic acid. This present study carried out induction for a period of 21 days in the GTa group. Given that 16.7 days for a rat is considered to be equivalent to a 12-month period for humans, the drug administration period for this group was comparable to 15 months. Accordingly, the equivalent time for GTb group would be a treatment period of 3 years and 4 months. 16 The weekly dose used in this study was 0.2 mg/kg. In general, the dose administered to humans is 4 mg via infusion each 3-4 weeks. If the average weight of a patient is considered to be 70 kg, the dose being administered is 0.06 mg/kg. When calculating the dose and its application intervals for this study, the authors considered the differences between the bone metabolism of the two species. The larger dose used for the rats in comparison with that used for humans is due to their accelerated metabolism and high rate of bisphosphonate excretion, which is characteristic of this animal model.
The defect created in the crown of the lower first molars intended to mimic pulp changes and inflammatory processes in the periapical region, similar to those generated by dental caries and its progression. The section in proximity to the dental furcation area frequently exhibited an acute inflammatory process. However, this could not be regarded as a region of interest due to dental fractures originating from the trauma applied by the drill to the dental crowns, which could not be standardized. Therefore, it was defined that the group analysis would include the apical region as this area reflects pulp changes.
Changes in the capacity of the reaction of dental support tissues in the mandible were observed after drill-induced damage to the crown of the lower first molars. It is believed that the continued deposition of mineralized tissue, absence of osteoclast remodelling and decreased blood supply led to higher grey levels in the 3-week GTa test group in comparison with the corresponding GCa control group.
Maintaining the therapy for 8 weeks led to a very different outcome, showing a decrease in grey levels. Necrotic zones accompanied by an acute inflammatory process were observed. The increase in cytokines arising from this inflammatory process possibly contributed to its continuation. The reaction process in the dental support tissues remained slower in the group receiving the medication (GTa) compared to the control group (GCa).
In this study the lower molar alveolar ridges of test groups also showed little remodelling in comparison with control groups. Mandibular bone resorption in these groups was altered by the drug not only regarding the osteoclast function, but also suggesting changes in bone deposition. Such observations have already been reported in vitro and revealed cellular changes caused by bisphosphonates in structures other than osteoclasts, 8 suggesting that there are alterations in the osteoblast synthesis mechanisms due to the medication, which should be further investigated.
The present study shows that the inflammatory response of alveolar bone tissue in rats was modified by 3-week zoledronic acid interrupted therapy, observed through changes in tomography grey levels. The continued 8-week zoledronic acid therapy appeared to exacerbate the periapical inflammatory reaction, with the emergence of necrotic zones and absent of bone remodelling.
